首页>International journal of molecular medicine>miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
作者单位：Third Mil Med Univ, Med English Dept, Coll Basic Med, Chongqing 400038, Peoples R China[1]Third Mil Med Univ, Canc Inst PLA, Xinqiao Hosp, 183 Xinqiao Ctr St, Chongqing 400037, Peoples R[2]
换一批
换一批
